Tibet Weixinkang Medicine Co Ltd (603676) — Capital Reinvestment Ratio
Tibet Weixinkang Medicine Co Ltd (603676) has a Capital Reinvestment Ratio of 1.36x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥13.68 Million) in capital expenditures (CN¥18.57 Million). Check 603676 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tibet Weixinkang Medicine Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Tibet Weixinkang Medicine Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Tibet Weixinkang Medicine Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Tibet Weixinkang Medicine Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. See Tibet Weixinkang Medicine Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥185.53 Million | CN¥83.92 Million | ▲ +189.8% |
| 2024 | 0.16x | CN¥372.78 Million | CN¥58.18 Million | ▼ -43.4% |
| 2023 | 0.28x | CN¥256.67 Million | CN¥70.81 Million | ▼ -12.6% |
| 2022 | 0.32x | CN¥246.15 Million | CN¥77.69 Million | ▼ -3.1% |
| 2021 | 0.33x | CN¥170.69 Million | CN¥55.60 Million | ▼ -19.9% |
| 2020 | 0.41x | CN¥133.70 Million | CN¥54.35 Million | ▼ -1.0% |
| 2019 | 0.41x | CN¥106.34 Million | CN¥43.65 Million | ▼ -63.9% |
| 2018 | 1.14x | CN¥83.17 Million | CN¥94.50 Million | ▼ -7.5% |
| 2017 | 1.23x | CN¥63.30 Million | CN¥77.76 Million | ▲ +382.9% |
| 2016 | 0.25x | CN¥103.79 Million | CN¥26.40 Million | ▼ -32.7% |
| 2015 | 0.38x | CN¥114.47 Million | CN¥43.29 Million | ▼ -36.9% |
| 2014 | 0.60x | CN¥118.47 Million | CN¥70.97 Million | ▼ -45.4% |
| 2013 | 1.10x | CN¥88.59 Million | CN¥97.29 Million | — |